|
CLDX Celldex Therapeutics Inc 744218 |
| Balance Sheet |
|
Current Assets
|
747,159,000 |
|
Assets
|
792,340,000 |
|
Current Liabilities
|
39,501,000 |
|
Liabilities
|
45,335,000 |
|
Equity
|
747,005,000 |
|
Shares Out
|
66,288,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-157,778,000 |
|
Investing Cash Flow
|
-290,129,000 |
| Market Analysis |
Market Cap
|
2,809,930,899 |
|
Price
|
19.81 |
|
BVPS
|
11.27 |
|
PB
|
1.75 |
|
EPS
|
-2.74 |
|
PS
|
100.07 |
|
FCF
|
-447,907,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLDX documents filed with the SEC.
CLDX Filings
Clear
